Drug Trial Radar · NCT02344290
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Last checked: Nov 20, 2026Latest source record: Sep 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
7,769
Actual
Start
Mar 26, 2015
Primary completion
Aug 21, 2023
Study completion Aug 21, 2023
Sponsor
- Sponsor type
- NIH
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI); Kowa Pharmaceuticals America, Inc.; Gilead Sciences; Massachusetts General Hospital; NEAT ID Foundation
- First posted
- Jan 22, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 40 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
People with HIV are at risk for cardiovascular disease (CVD). This study evaluated the use of pitavastatin to reduce the risk of CVD in adults with HIV on antiretroviral therapy (ART). The REPRIEVE trial consisted of two parallel identical protocols: * REPRIEVE (A5332) was funded by the NHLBI, with additional infrastructure support provided by the NIAID, and was conducted in U.S and select international sites (approximately 120 sites in 11 countries). * REPRIEVE (EU5332) was co-sponsored by NEAT ID and MGH, and was conducted at 13 sites in Spain.
Conditions
- HIV
- Cardiovascular Diseases
Interventions
PitavastatinDrug
One tablet (4 mg) taken once daily, orally with or without food
PlaceboDrug
One tablet taken once daily, orally with or without food
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence Rate of Major Adverse Cardiovascular Event (MACE)Time frame: From entry through end of study. Follow-up time varied depending on time of enrollment (the median follow-up time was 5.6 years).
Locations
137 sites in 13 countries. Site status is shown where the registry gives one.
Alabama CRS*
Birmingham, Alabama
University of Arizona CRS
Tucson, Arizona
University of Southern California CRS*
Los Angeles, California
UCLA CARE Center CRS*
Los Angeles, California
Mills Clinical Research CRS
Los Angeles, California
VA West Los Angeles Medical Center CRS
Los Angeles, California
Los Angeles LGBT Center CRS
Los Angeles, California
Eisenhower Health Center at Rimrock CRS
Palm Springs, California
Stanford AIDS Clinical Trials Unit CRS
Palo Alto, California
UCSD Antiviral Research Center CRS*
San Diego, California
Ucsf Hiv/Aids Crs*
San Francisco, California
Harbor-UCLA CRS*
Torrance, California
University of Colorado Hospital CRS*
Aurora, Colorado
Denver Public Health CRS
Denver, Colorado
Yale University CRS
New Haven, Connecticut
VA Connecticut Healthcare System CRS
West Haven, Connecticut
Whitman-Walker Health CRS
Washington D.C., District of Columbia
Georgetown University CRS (GU CRS)
Washington D.C., District of Columbia
Capital Medical Associates, PC CRS
Washington D.C., District of Columbia
Infectious Diseases Clinic, Washington DC Veterans Affairs Medical Center CRS
Washington D.C., District of Columbia
Malcom Randall VA Medical Center CRS
Gainesville, Florida
AHF-The Kinder Medical Group CRS
Miami, Florida
The University of Miami AIDS Clinical Research Unit (ACRU) CRS
Miami, Florida
University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS
Miami, Florida
AHF - South Beach CRS
Miami, Florida
Orlando Immunology Center CRS
Orlando, Florida
Community AIDS Network/Comprehensive Care Clinic CRS
Sarasota, Florida
Florida Department of Health - Hillsborough County
Tampa, Florida
AIDS Research and Treatment Center of the Treasure Coast CRS
Vero Beach, Florida
The Ponce de Leon Center CRS
Atlanta, Georgia
Augusta University Research Institute, Inc. CRS
Augusta, Georgia
Northwestern University CRS*
Chicago, Illinois
Rush University CRS*
Chicago, Illinois
UIC Project WISH CRS
Chicago, Illinois
Indiana University Infectious Diseases Research CRS
Indianapolis, Indiana
Department of Internal Medicine, University of Iowa Hospitals & Clinics CRS
Iowa City, Iowa
Bluegrass Care Clinic/University of Kentucky Research Foundation CRS
Lexington, Kentucky
550 Clinic -University of Louisville CRS
Louisville, Kentucky
Tulane - Louisiana Community AIDS Research Program (T-LaCARP) CRS
New Orleans, Louisiana
Johns Hopkins University CRS*
Baltimore, Maryland
Showing 40 of 137 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.